Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment - Evans, D.R; Parikh, V.V; Khan, M.M; Coussons, C; Buckley, P.F; Mahadik, S.P (Prostaglandins, leukotrienes and essential fatty acids, 2003)
Keywords: Adult; Alkanes - blood; Antioxidants - therapeutic use; Antipsychotic Agents - therapeutic use; Antipsychotics; Drug Therapy, Combination; Erythrocyte Membrane - drug effects; Erythrocyte Membrane - metabolism; Erythrocytes - enzymology; Essential fatty acids; Fatty Acids, Essential - blood; Fatty Acids, Omega-3 - therapeutic use; Fatty Acids, Unsaturated - blood; Humans; Lipid Peroxides - blood; Membrane phospholipids; Oxidative Stress; Psychotic Disorders - blood; Schizophrenia; Schizophrenia; NA, nervonic acid; Essential fatty acids; GSHPX, glutathione peroxidase; DHA, docosahexaenoic acid; SOD, superoxide dismutase; Antipsychotics; FEP, first episode of psychosis; AA, arachidonic acid; CAT, catalase; Membrane phospholipids; EPUFAs, essential polyunsaturated fatty acids; PANSS, positive and negative symptom scale; BPRS, brief psychiatric rating scale